Commentary

Published in:
Volume 2 / Year 2013 / Issue 4

Maximizing quality in the manufacture of biologicals

Author(s): ,
Page: 170-2

Abstract: Biological product quality is susceptible to unexpected manufacturing issues, and the resulting variation may impact the safety or efficacy of these medicines and increase risks to patients. These risks… Read More »

Go Back Print